We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Amplify Energy
AMPY
$158M
| $105K | ﹤0.01% |
22,992
+7,201
| +46% | +$35.8K |
|
2627
Grocery Outlet
GO
$904M
| $105K | ﹤0.01% |
+10,376
| New | +$131K |
|
2628
Acumen Pharmaceuticals
ABOS
$152M
| $105K | ﹤0.01% |
+49,563
| New | +$98.3K |
|
2629
908 Devices
MASS
$312M
| $104K | ﹤0.01% |
19,852
-25,184
| -56% | -$176K |
|
|
TEAD
2630
Teads Holding Co
TEAD
$76.2M
| $104K | ﹤0.01% |
147,599
+115,029
| +353% | +$122K |
|
2631
Compugen
CGEN
$212M
| $104K | ﹤0.01% |
+67,903
| New | +$113K |
|
2632
Kamada
KMDA
$404M
| $103K | ﹤0.01% |
+14,566
| New | +$101K |
|
2633
Enel Chile
ENIC
$6.03B
| $103K | ﹤0.01% |
+25,570
| New | +$98.5K |
|
|
BMNU
2634
T-REX 2X Long BMNR Daily Target ETF
BMNU
$218M
| $101K | ﹤0.01% |
+2,123
| New | +$325K |
|
|
GLQ
2635
Clough Global Equity Fund
GLQ
$151M
| $101K | ﹤0.01% |
+13,167
| New | +$101K |
|
|
WIW
2636
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$506M
| $101K | ﹤0.01% |
+11,722
| New | +$103K |
|
2637
AmpliTech
AMPG
$117M
| $101K | ﹤0.01% |
+33,637
| New | +$114K |
|
2638
Douglas Elliman
DOUG
$156M
| $101K | ﹤0.01% |
42,407
-173,529
| -80% | -$446K |
|
2639
Skillsoft
SKIL
$66.3M
| $100K | ﹤0.01% |
+10,781
| New | +$120K |
|
2640
Atossa Therapeutics
ATOS
$23M
| $99.9K | ﹤0.01% |
11,284
+9,627
| +581% | +$122K |
|
|
TTRX
2641
Turn Therapeutics
TTRX
$221M
| $99.2K | ﹤0.01% |
+25,173
| New | +$105K |
|
2642
Better Online Solutions
BOSC
$31.7M
| $97.6K | ﹤0.01% |
21,410
+6,334
| +42% | +$30.8K |
|
2643
KRONOS Worldwide
KRO
$712M
| $97.5K | ﹤0.01% |
22,068
-12,249
| -36% | -$59.5K |
|
|
NIU
2644
Niu Technologies
NIU
$200M
| $97.1K | ﹤0.01% |
+32,040
| New | +$124K |
|
2645
Kearny Financial
KRNY
$604M
| $96.8K | ﹤0.01% |
+13,064
| New | +$90.2K |
|
2646
Northern Technologies International Corp
NTIC
$75.6M
| $96.3K | ﹤0.01% |
+12,305
| New | +$94.5K |
|
2647
Lifestance Health
LFST
$4.15B
| $95.7K | ﹤0.01% |
+13,588
| New | +$82K |
|
2648
Achieve Life Sciences
ACHV
$633M
| $94.9K | ﹤0.01% |
19,092
-66,763
| -78% | -$291K |
|
2649
Phunware
PHUN
$42.9M
| $94.9K | ﹤0.01% |
51,289
+32,812
| +178% | +$76.3K |
|
2650
CPS Technologies
CPSH
$67.6M
| $94.8K | ﹤0.01% |
+30,687
| New | +$109K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.